Hiroshima University-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2024

  1. KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination

    Cell Communication and Signaling, Vol. 22, Núm. 1